Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts

A E Levy1, J W Alexander, G F Babcock

  • 1University of Cincinnati, Medical Center, Department of Surgery, Cincinnati, OH 45267-0558, USA.

Transplant Immunology
|June 1, 1997
PubMed
Summary

A repeated short-term immunosuppression protocol using donor-specific transfusions (DST), cyclosporine (CsA), and rapamycin (Rapa) significantly improved long-term graft survival in rats. This approach offers a promising alternative to current immunosuppression strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calcineurin deficiency decreases inflammatory lesions in transforming growth factor beta1-deficient mice.

Clinical and experimental immunology·2009
Same author

Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.

Oncogene·2007
Same author

Outcomes with the selective use of enteric exocrine drainage in pancreas transplantation.

Transplantation proceedings·2005
Same author

Rescue of acute portal vein thrombosis after liver transplantation using a cavoportal shunt at re-transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2002
Same author

Unresectable hepatocellular carcinoma: the need for an individualized multidisciplinary approach.

Journal of clinical gastroenterology·2001
Same author

Inhibition of melanosome transfer from melanocytes to keratinocytes by lectins and neoglycoproteins in an in vitro model system.

Pigment cell research·2001

Area of Science:

  • Immunology
  • Transplantation Biology
  • Pharmacology

Background:

  • Current triple drug immunosuppression strategies, while effective, carry significant risks of opportunistic infections and lymphoproliferative disorders.
  • Developing donor-specific tolerance through short-term interventions is a critical goal in transplantation to mitigate these risks.

Purpose of the Study:

  • To investigate if a repeated perioperative administration of donor-specific transfusions (DST) combined with cyclosporine (CsA) and rapamycin (Rapa) could enhance donor-specific tolerance in a rat cardiac transplant model.
  • To compare the efficacy of different dosing regimens of DST/CsA/Rapa in achieving long-term graft survival and donor-specific tolerance.

Main Methods:

  • ACI to Lewis rat heterotopic cardiac transplantation model.
  • Recipients were assigned to various treatment groups receiving DST, CsA, and Rapa with different dosing schedules, including a repeated monthly regimen.

Related Experiment Videos

  • Graft survival, donor specificity, mixed lymphocyte response, and cytokine profiles were assessed.

    • Main Results:

    • Protocols involving repeated administration of DST/CsA/Rapa (groups 4-6) demonstrated significantly higher permanent graft survival (>200 days) compared to control groups (1-3).
    • Donor-specific tolerance was confirmed in group 6, with permanent survivors rejecting a second donor-specific allograft rapidly and showing reduced mixed lymphocyte responses to donor cells.
    • A shift towards Th-2 type cytokines (IL-4) and reduced overall T cell cytokine production were observed.

    Conclusions:

    • A repeated short-term DST/CsA/Rapa treatment protocol can induce consistent and durable donor-specific graft survival, achieving up to 91% success in the rat model.
    • This regimen represents a significant advancement over previously studied tolerance induction protocols.
    • The findings suggest a viable alternative to current long-term immunosuppression, potentially reducing associated morbidities.